How telehealth prescribing works across state lines

Telehealth feels placeless. The law is not. Every state regulates the practice of medicine on people inside its borders, and the visit is treated as happening where the patient is. That single rule explains most of what follows.

Rule one: the patient's state governs

If you are in Georgia during the video call, Georgia law governs the visit, the Georgia Composite Medical Board licenses the prescriber, and a Georgia pharmacy licence (resident or non-resident) is needed by whoever ships the medication to you. It does not matter that the company is registered in Delaware, the prescriber lives in Florida, or the pharmacy is in Texas. This is why every state page on this site starts with the licence lookups for that state and not with the company.

Travel changes the answer. A visit taken from a hotel in another state is governed by that state. Programs that ask "which state are you in right now?" before a visit are asking the legally correct question.

Rule two: the prescriber needs authority in that state

Authority usually means a full licence from the state board. Three other routes exist, and the state card notes them where we saw them in the statute:

• A compact licence. In the 44 member states and DC, a physician licensed in one member state can obtain full licences in others through the Interstate Medical Licensure Compact. The result is an ordinary state licence and shows on the board lookup.
• A telehealth registration or permit. Some states let an out-of-state physician register to provide telehealth to their residents without a full licence, usually with conditions (no in-person practice in the state, no controlled substances, a disciplinary record clean of restrictions). Florida's out-of-state telehealth provider registration is the best-known example and is searchable in the same Florida lookup as physicians.
• Narrow exceptions for consultations with an in-state physician, follow-up of an established patient who is temporarily out of state, and emergencies. These do not cover a new weight-management patient recruited by an advertisement.

Whichever route applies, the licence check is the same: search the board of the state you were in.

Rule three: the in-person exam question is state law

Whether a prescriber may issue a first prescription after a telehealth encounter, with no prior in-person examination, is set by each state's medical practice act, telehealth statute or board rule. Three patterns cover nearly everything:

1. No in-person exam required. The statute says a practitioner-patient relationship may be established by telehealth, or that telehealth is held to the same standard of care as in-person care with no separate exam requirement. Most states are here for non-controlled drugs.
2. Allowed with conditions. For example, the first encounter must be real-time audio and video; or a questionnaire alone is not enough; or after a set number of telehealth-only visits an in-person visit is required; or the prescriber must hold a specific registration.
3. In-person required. Rare for non-controlled drugs today, but boards can impose it for particular situations, and rules change.

Our state cards report which pattern applies only when we have loaded the statute or rule text ourselves. The citation and a link sit on the card. Where we have not, the card says "check with the board" and links the board. We do not paraphrase secondary summaries into a rule, because a summary that is a year old is often wrong.

Two things the in-person question does not change. The standard of care is the same as in an office: for a GLP-1 that means a history, current medications, relevant conditions, a weight and height, and a follow-up plan. And the prescription must be patient-specific; a program that dispenses without an individual prescriber decision is outside every state's rules and is the kind of operation FDA's March 3, 2026 letters describe.

Why GLP-1s are simpler than controlled drugs

Semaglutide, tirzepatide and liraglutide are not controlled substances. Controlled drugs add a federal layer: the Ryan Haight Act (21 U.S.C. 829(e)) generally requires an in-person evaluation before a controlled substance is prescribed over the internet, subject to exceptions and to temporary telemedicine flexibilities that DEA has extended more than once. None of that applies to GLP-1s. If a program also offers a controlled drug (phentermine is the common one in weight management), the controlled-drug rules apply to that prescription and are outside this site's scope.

How to use the state cards

Open the page for the state you will be in. Read the telehealth row: if it quotes a statute, follow the link and read the sentence yourself; it is usually short. Then run the prescriber lookup in the first row and the pharmacy lookup in the second. If you split time between two states, the state lookup tool shows two cards side by side. For what a good telehealth intake looks like and what to ask, the Choosing a GLP-1 Clinic site covers the care side; the FormBlends regulatory status page tracks the federal position on compounded products.